Bioavailability / Bioequivalence Services

Delivering audit-ready, protocol-driven oversight for global regulatory success

Bioequivalence Study Monitoring Services

Enabling Regulatory Confidence Through Precision Oversight

We deliver BE study monitoring aligned with global regulations (ICH-GCP, FDA, EMA, WHO, CDSCO) enabling inspection-ready data across geographies.

  • Protocol Compliance Monitoring: SOP, 21 CFR, EU CTR 536/2014 alignment and real-time deviation management.
  • Clinical Phase Oversight: Monitors trained in dosing, PK fidelity, informed consent & crossover designs.
  • Risk-Based Site Monitoring: Facility, equipment, and cold chain inspections per FDA/EMA mandates.
  • SDV & eCRF Validation: TransCelerate RBM methodology for GxP compliance.
  • AE & Deviation Management: ICH E2A, MedDRA coded, CAPA-driven event tracking.
  • Monitoring Deliverables: eCTD-ready reports, logs, and query resolution summaries.

Why Sponsors Choose SafeVig:

  • GCP-certified early-phase clinical monitors
  • Supports BE/BA, 505(b)(2), global bridging studies
  • Lifecycle support from site to CSR
  • Proven compliance with USFDA, ANSM, CDSCO

Bioavailability Study Monitoring Services

Advancing Regulatory Success Through Precision and Scientific Integrity

We offer BA study monitoring aligned with ICH-GCP, FDA, EMA, CDSCO, TGA, and Health Canada to enable reproducible, regulatory-accepted data.

  • Compliance Oversight: Aligned with ICH E6(R2), 21 CFR Parts 50 & 56, EU 2001/20/EC. Ensures criteria adherence and informed consent documentation.
  • PK Sampling Oversight: Predefined logs, matrix-specific timing, real-time supervision.
  • Sample Chain of Custody: GLP, audit trails, validated bioanalytical logistics.
  • Source Document Review: 100% SDV + RBM hybrid verification with traceability.
  • AE Management: Integrated CAPA, ICH E2A, real-time escalation framework.
  • Monitoring Output: Visit reports, site metrics, reconciled data logs, eCTD-ready.

Why SafeVig for BA:

  • Expert PK monitors for SD/MD, fed/fasted, special populations
  • eTMF, eCRF, RBM dashboards for efficient oversight
  • Centers in LATAM, Southeast Asia, India, EU
  • Supports small molecules, MR, 505(b)(2), nutraceuticals